Erratum: Metabolic Syndrome and Transplantation (American Journal of Transplantation (2010) 10(1) (12–17), (S1600613522195365), (10.1111/j.1600-6143.2009.02882.x));Metabolic syndrome and solid-organ transplantation: Minireview

American Journal of Transplantation

Volumn 10, Issue 1, 2010, Pages 12-17

  Sharif, A ^a  

^a QUEEN ELIZABETH HOSPITAL   (United Kingdom)

Author keywords

Cardiovascular disease; Hyperglycemia; Infectious complications; Malignancy; Metabolic complications; Metabolic disorders; Transplantation

Indexed keywords

ADIPONECTIN; APOLIPOPROTEIN C3; APOLIPOPROTEIN E; CALCINEURIN; CORTICOSTEROID DERIVATIVE; CYCLOSPORIN; FATTY ACID; INSULIN; STEROID; TACROLIMUS; TUMOR NECROSIS FACTOR ALPHA;

ADIPOCYTE; ADIPOSE TISSUE; ARTERY CALCIFICATION; ATHEROGENESIS; ATHEROSCLEROSIS; BODY MASS; CANCER MORTALITY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CORONARY ARTERY; CYTOMEGALOVIRUS INFECTION; DIABETES MELLITUS; DYSLIPIDEMIA; ENDOTHELIAL DYSFUNCTION; GENETIC POLYMORPHISM; GRAFT FAILURE; GRAFT REJECTION; HEPATITIS C; HEREDITY; HORMONE BLOOD LEVEL; HUMAN; HYPERCOAGULABILITY; IMMUNE DEFICIENCY; IMMUNOSUPPRESSIVE TREATMENT; INFECTION; INFLAMMATION; INSULIN RESISTANCE; INSULIN SENSITIVITY; KIDNEY TRANSPLANTATION; LIVER FIBROSIS; LIVER GRAFT; LIVER TRANSPLANTATION; METABOLIC SYNDROME X; NEOPLASM; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; ORGAN TRANSPLANTATION; PATHOPHYSIOLOGY; POSTOPERATIVE COMPLICATION; PREVALENCE; PRIORITY JOURNAL; SHORT SURVEY; SURGICAL RISK; TREATMENT OUTCOME; VASCULAR DISEASE;

EID: 72549098579     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2012.04066.x     Document Type: Erratum

References (30)

1. Reaven GM. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 1988 37 : 1595 1607.
2. de Vries AP, Bakker SJ, van Son WJ et al. Metabolic syndrome is associated with impaired long-term renal allograft function; not all component criteria contribute equally. Am J Transplant 2004 4 : 1675 1683.
3. Rodrigo E, Fernandez-Fresnedo G, Valero R et al. New-onset diabetes after kidney transplantation: Risk factors. J Am Soc Nephrol 2006 17 (12 Suppl 3 S291 S295.
4. Armstrong KA, Campbell SB, Hawley CM, Nicol DL, Johnson DW, Isbel NM. Obesity is associated with worsening cardiovascular risk factor profiles and proteinuria progression in renal transplant recipients. Am J Transplant 2005 5 : 2710 2718.
5. Hjelmesaeth J, Flyvbjerg A, Jenssen T et al. Hypoadiponectinemia is associated with insulin resistance and glucose intolerance after renal transplantation: Impact of immunosuppressive and antihypertensive drug therapy. Clin J Am Soc Nephrol 2006 1 : 575 582.
6. Nishimura K, Kishikawa H, Kato T et al. Tacrolimus and angiotensin receptor blockers associated with changes in serum adiponectin level in new-onset diabetes after renal transplantation: Single-center cross-sectional analysis. Transpl Int 2009 22 : 694 701.
7. Genis BB, Granada ML, Alonso N et al. Ghrelin, glucose homeostasis, and carotid intima media thickness in kidney transplantation. Transplantation 2007 84 : 1248 1254.
8. von Eynatten M, Hamann A, Twardella D, Nawroth PP, Brenner H, Rothenbacher D. Atherogenic dyslipidaemia but not total- and high-molecular weight adiponectin are associated with the prognostic outcome in patients with coronary heart disease. Eur Heart J 2008 29 : 1307 1315.
9. Rodrigo E, Gonzalez-Lamuno D, Ruiz JC et al. Apolipoprotein C-III and E polymorphisms and cardiovascular syndrome, hyperlipidemia, and insulin resistance in renal transplantation. Am J Transplant 2002 2 : 343 348.
10. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: Diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 1998 15 : 539 553.
11. Balkau B, Charles MA, Drivsholm T et al. Frequency of the WHO metabolic syndrome in European cohorts, and an alternative definition of an insulin resistance syndrome. Diabetes Metab 2002 28 : 364 376.
12. Grundy SM, Brewer HB Jr., Cleeman JI, Smith SC Jr., Lenfant C. Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation 2004 109 : 433 438.
13. Alberti KG, Zimmet P, Shaw J. Metabolic syndrome - a new world-wide definition. A Consensus Statement from the International Diabetes Federation. Diabet Med 2006 23 : 469 480.
14. Wilson PW, D'Agostino RB, Parise H, Sullivan L, Meigs JB. Metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitus. Circulation 2005 112 : 3066 3072.
15. Ho JS, Cannaday JJ, Barlow CE, Mitchell TL, Cooper KH, FitzGerald SJ. Relation of the number of metabolic syndrome risk factors with all-cause and cardiovascular mortality. Am J Cardiol 2008 102 : 689 692.
16. Jaggers JR, Sui X, Hooker SP et al. Metabolic syndrome and risk of cancer mortality in men. Eur J Cancer 2009 45 : 1831 1838.
17. Nabipour I, Vahdat K, Jafari SM, Pazoki R, Sanjdideh Z. The association of metabolic syndrome and Chlamydia pneumoniae, Helicobacter pylori, cytomegalovirus, and herpes simplex virus type 1: The Persian Gulf Healthy Heart Study. Cardiovasc Diabetol 2006 5 : 25 30.
18. Porrini E, Delgado P, Bigo C et al. Impact of metabolic syndrome on graft function and survival after cadaveric renal transplantation. Am J Kidney Dis 2006 48 : 134 142.
19. Hanouneh IA, Feldstein AE, McCullough AJ et al. The significance of metabolic syndrome in the setting of recurrent hepatitis C after liver transplantation. Liver Transpl 2008 14 : 1287 1293.
20. Courivaud C, Kazory A, Simula-Faivre D, Chalopin JM, Ducloux D. Metabolic syndrome and atherosclerotic events in renal transplant recipients. Transplantation 2007 83 : 1577 1581.
21. Laryea M, Watt KD, Molinari M et al. Metabolic syndrome in liver transplant recipients: Prevalence and association with major vascular events. Liver Transpl 2007 13 : 1109 1114.
22. Armstrong K, Rakhit D, Jeffriess L et al. Cardiorespiratory fitness is related to physical inactivity, metabolic risk factors, and atherosclerotic burden in glucose-intolerant renal transplant recipients. Clin J Am Soc Nephrol 2006 1 : 1275 1283.
23. Adeseun GA, Rivera ME, Thota S, Joffe M, Rosas SE. Metabolic syndrome and coronary artery calcification in renal transplant recipients. Transplantation 2008 86 : 728 732.
24. Reaven GM. The metabolic syndrome: Is this diagnosis necessary? Am J Clin Nutr 2006 83 : 1237 1247.
25. Gami AS, Witt BJ, Howard DE et al. Metabolic syndrome and risk of incident cardiovascular events and death: A systematic review and meta-analysis of longitudinal studies. J Am Coll Cardiol 2007 49 : 403 414.
26. Kasiske BL, Guijarro C, Massy ZA, Wiederkehr MR, Ma JZ. Cardiovascular disease after renal transplantation. J Am Soc Nephrol 1996 7 : 158 165.
27. Sharif A, Ravindran V, Dunseath G, Luzio S, Owens D, Baboolal K. Comparison of rival metabolic syndrome classifications against pathophysiological markers in renal transplant recipients. Transplantation 2009 (in press).
28. Sharif A, Ravindran V, Moore R et al. Insulin resistance indexes in renal transplant recipients maintained on tacrolimus immunosuppression. Transplantation 2009 (in press).
29. United States Renal Data System. USRDS 2008 Annual Data Report 2008 Available from : http://www.usrds.org.2008.
30. Gaston RS, Kasiske BL, Fieberg AM et al. Use of cardioprotective medications in kidney transplant recipients. Am J Transplant 2009 9 : 1811 1815.